Back

Safety and efficacy of very high-power short ablation in superior vena cava isolation in patients with atrial fibrillation

8 April 2024 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 3 - ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Yuhi Fujimoto

Nippon Medical School Teaching Hospital, Tokyo (Japan)

7 More presentations in this session

Presentation thumbnail
Very-high power short duration radiofrequency ablation (90W/4seconds) under mild conscious sedation: lesion metrics and 12-month outcomes
Doctor M. Mills (Sheffield, GB)
Abstract Slides Video
Presentation thumbnail
The impact of cardiac rehabilitation on atrial fibrillation recurrence after pulmonary vein isolation: results of a retrospective study.
Miss R. Onder (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
Pressure-guided evaluation of pulmonary vein occlusion during cryoballoon pulmonary vein isolation for atrial fibrillation compared to contrast-guided approach
Mr O. Alothman (Bad Berka, DE)
Abstract Slides Video
Presentation thumbnail
Low voltage area in the left atrial anterior wall predict Marshall-PLAN failure in patients with persistent atrial fibrillation.
Doctor L. Limite (Perpignan, FR)
Abstract Slides Video
Presentation thumbnail
Endoscopic versus surgical treatment for the management of oesophageal fistula after atrial fibrillation ablation - a subanalysis of the worldwide POTTER-AF study
Doctor S. Popescu (Luebeck, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 3 - ablation

The Event

Event poster

EHRA 2024

8 April 2024 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Superior vena cava isolation in paroxysmal atrial fibrillation - mind the phrenic
thumbnail
Congress Presentation
Electroanatomical properties of the superior vena cava - the vein, born for isolation.
thumbnail
Congress Presentation
Superior vena cava is associated with improved outcomes in atrial fibrillation ablation, as part of a patient- tailored approach: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources